Wits VIDA publishes important work on interrogating Covid vaccine hesitancy in Soweto Wits VIDA publishes important work on interrogating Covid vaccine hesitancy in Soweto 2022-12-29T12:57:17+02:0002 Dec 2022|
Witsies win lifetime achievement, research, and capacity development awards at Science Oscars Witsies win lifetime achievement, research, and capacity development awards at Science Oscars 2022-08-06T10:57:37+02:0022 Jul 2022|
Novavax Covid-19 vaccine trial results show efficacy against the B.1.351 variant in SA study Novavax Covid-19 vaccine trial results show efficacy against the B.1.351 variant in SA study 2022-03-25T09:56:47+02:0025 Mar 2022|
New project will examine Covid-19 vaccine acceptance in southern Africa New project will examine Covid-19 vaccine acceptance in southern Africa 2022-03-25T09:40:49+02:0016 Mar 2022|
The goal: Vaccinate 70% of the world against COVID. Scientists are proposing a reboot The goal: Vaccinate 70% of the world against COVID. Scientists are proposing a reboot 2022-03-25T08:49:59+02:0014 Mar 2022|
New promising interventions to protect term and premature babies from deadly respiratory virus New promising interventions to protect term and premature babies from deadly respiratory virus 2022-03-25T09:41:50+02:0011 Mar 2022|
Population based survey reveals why SA is at a turning point in the pandemic Population based survey reveals why SA is at a turning point in the pandemic 2022-03-25T09:37:30+02:0024 Feb 2022|
UC Davis Research: Prof Madhi on Omicron – The South African Experience 2022-03-25T08:55:35+02:0015 Feb 2022|
Living with COVID-19: Don’t let your masks down Living with COVID-19: Don’t let your masks down 2022-03-25T09:30:56+02:0014 Jan 2022|
Milder, more contagious: What scientists know about Omicron in South Africa Milder, more contagious: What scientists know about Omicron in South Africa 2022-03-25T09:33:43+02:0015 Dec 2021|